Mosunetuzumab cytotoxicity assays

ZA Zhiwei Ang
LP Luca Paruzzo
KH Katharina E. Hayer
CS Carolin Schmidt
MD Manuel Torres Diz
FX Feng Xu
UZ Urvi Zankharia
YZ Yunlin Zhang
SS Samantha Soldan
SZ Sisi Zheng
CF Catherine D. Falkenstein
JL Joseph P. Loftus
SY Scarlett Y. Yang
MA Mukta Asnani
PS Patricia King Sainos
VP Vinodh Pillai
EC Emeline Chong
ML Marilyn M. Li
ST Sarah K. Tasian
YB Yoseph Barash
PL Paul M. Lieberman
MR Marco Ruella
SS Stephen J. Schuster
AT Andrei Thomas-Tikhonenko
request Request a Protocol
ask Ask a question
Favorite

OCI-Ly8 was transduced to express green click beetle luciferase and ZsGreen using pHIV-Luc-ZsGreen (a gift from Bryan Welm [Addgene plasmid no. 39196]). These cells were cultured with healthy donor T cells (E:T ratio of 5:1) and different concentrations of mosunetuzumab (Genentech and Roche): 0, 1, 10, and 100 ng/ml. After 24 hours, cancer cell survival was monitored by luciferase bioluminescence using a BioTek Synergy H4 Imager (560 nm). Cell viability (%) was calculated relative to that of the Ctrl cancer cells and T cells without mosunetuzumab.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A